Global Oligonucleotides Synthesis Market – Industry Trends and Forecast to 2026

  • Healthcare IT
  • Published Report
  • Aug 2019
  • Global
  • 350 Pages
  • No of Tables: 374
  • No of Figures: 50

Global Oligonucleotides Synthesis Market By Product Type (DNA Oligonucleotides, RNA Oligonucleotides), Type (Oligonucleotide-Based Drugs, Primers, Probes, Intermediate-Scale Synthesized Oligos, Large-Scale Synthesized Oligos, Linkers & Adaptors, Array-Based Oligos), Consumables (Instruments, Kits & Reagents, Others), Service Type (Custom Oligos, Predesigned Oligos, Oligo Synthesis), Application (Research Applications, Therapeutic Applications, Diagnostic Applications, Others), End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Hospitals, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2026

Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.

The oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures. Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.

The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.

The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.

Global oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.

Segmentation: Global Oligonucleotides Synthesis Market

Global oligonucleotides synthesis market is segmented into six notable segments which are product type, type, consumables, service type, application and end user.

  • On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.

    • In March 2015, TriLink BioTechnologies, LLC introduced their new technology Clean Tag which is designed to provide efficiency in the NGS library preparation. The technology is designed for the clinical research purpose that helps in eliminating the gel purification process and advances the work flow method. The introduction of the new technology helping the researchers in NGS library and enhancing the advanced product offering of the company.

  • On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.

    • In September 2018, Maravai LifeSciences (U.S.) announced the lease of new facility to expand the business of lifescience sector for TriLink BioTechnologies, LLC in San Diego, U.S. The new facility will help the company to make the business position globally and helps for the continuous growth in the life science market.

  • On the basis of consumables, the market is segmented into instruments, kits & reagents and others.

    • In May 2019, QIAGEN announced launch of PIK3CA RGQ PCR kit to improve the health of patient with breast cancer. This uses plasma specimens during liquid biopsy. With this there will be improved diagnostics for genetic abnormalities and hence increased product portfolio of a company.

  • On the basis of service type, the market is segmented into custom oligos, predesigned oligos and oligo synthesis.

    • In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases. GMP is certified by Belgium Authorities. With this there is an increased production of clinical and pre-clinical Oligonucleotides.

  • On the basis of application, the market is segmented into research applications, therapeutic applications, diagnostic applications and others.

    • In April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing. This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.

  • On the basis of end user, the market is segmented into biopharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, hospitals and others.

    • In December 2018, Biolytic Lab Performance Inc. introduced the Dr. Oligo 192c which is designed for the synthesis of bio molecules. The redesign of the Dr. Oligo 48 enhances the process output and helping the researchers in the cost reduction in synthesis process. The new introduction of the instrument will expand the business of the company globally and helps in offering the product overseas.

Competitive Analysis: Global Oligonucleotides Synthesis Market

Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.

Product Launch

  • In April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing. This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.
  • In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases. GMP is certified by Belgium Authorities. With this there is an increased production of clinical and pre-clinical Oligonucleotides.

Research Methodology: Global Oligonucleotides Synthesis Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.


SKU-

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID

2.8 DBMR VENDOR SHARE ANALYSIS

2.9 MULTIVARIATE MODELING

2.1 PRODUCTS LIFELINE CURVE

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING USAGE OF SYNTHESIZED OLIGOS IN MOLECULAR DIAGNOSTICS AND CLINICAL APPLICATIONS

3.1.2 INCREASING GOVERNMENT INVESTMENTS, R&D EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

3.2 GENETIC DISORDERS

3.3 RESTRAINTS

3.3.1 LACK OF SKILLED PROFESSIONALS

3.3.2 INCREASING IN-HOUSE PRODUCTION HINDERING THE GLOBAL MARKET GROWTH

3.4 OPPORTUNITIES

3.4.1 STRATEGIC INITIATIVES OF THE MARKET PLAYERS

3.5 DEVELOPMENTS AND INNOVATIONS OF NEW PRODUCTS

3.6 CHALLENGES

3.6.1 STRINGENT REGULATIONS

3.6.2 DRUG DELIVERY & TOXICOLOGY CHALLENGES

4 EXECUTIVE SUMMARY

4.1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: SEGMENTATION

4.2 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026

5 PREMIUM INSIGHTS

5.1 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH AMERICA IS THE MOST PROFITABLE REVENUE POCKETS FOR GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 DNA OLIGONUCLEOTIDES

6.3 RNA OLIGONUCLEOTIDES

7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE

7.1 OVERVIEW

7.2 OLIGONUCLEOTIDE-BASED DRUGS

7.3 PRIMERS

7.4 PROBES

7.5 INTERMEDIATE-SCALE SYNTHESIZED OLIGOS

7.6 LARGE-SCALE SYNTHESIZED OLIGOS

7.7 LINKERS & ADAPTORS

7.8 ARRAY-BASED OLIGOS

8 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES

8.1 OVERVIEW

8.2 INSTRUMENTS

8.3 KITS & REAGENTS

8.4 OTHERS

9 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE

9.1 OVERVIEW

9.2 CUSTOM OLIGOS

9.2.1 MODIFICATION

9.2.2 PURIFICATION

9.3 PREDESIGNED OLIGOS

9.4 OLIGO SYNTHESIS

9.4.1 1000 NMOL

9.4.2 5,000 NMOL

9.4.3 100-200 NMOL

9.4.4 25-50 NMOL

9.4.5 10,000 NMOL

9.4.6 MORE THAN 10,000 NMOL

10 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 RESEARCH APPLICATIONS

10.2.1 PCR

10.2.2 QPCR

10.2.3 SEQUENCING

10.2.4 GENE SYNTHESIS

10.2.5 FLUORESCENCE IN SITU HYBRIDIZATION (FISH)

10.2.6 DNA MICROARRAYS

10.2.7 OTHER APPLICATIONS

10.3 THERAPEUTIC APPLICATIONS

10.3.1 DNA & ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES

10.3.2 RNAI OLIGONUCLEOTIDE-BASED THERAPIES

10.3.3 CPG OLIGONUCLEOTIDE-BASED THERAPIES

10.3.4 OTHERS

10.4 DIAGNOSTIC APPLICATIONS

10.5 OTHERS

11 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER

11.1 OVERVIEW

11.2 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

11.3 ACADEMIC & RESEARCH INSTITUTES

11.4 CONTRACT RESEARCH ORGANIZATIONS

11.5 HOSPITALS

11.6 OTHERS

12 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY GEOGRAPHY

12.1 OVERVIEW

12.2 NORTH AMERICA

12.2.1 U.S.

12.2.2 CANADA

12.2.3 MEXICO

12.3 EUROPE

12.3.1 GERMANY

12.3.2 U.K.

12.3.3 FRANCE

12.3.4 SWITZERLAND

12.3.5 ITALY

12.3.6 BELGIUM

12.3.7 DENMARK

12.3.8 SWEDEN

12.3.9 SPAIN

12.3.10 NETHERLANDS

12.3.11 RUSSIA

12.3.12 TURKEY

12.3.13 REST OF EUROPE

12.4 ASIA-PACIFIC

12.4.1 CHINA

12.4.2 JAPAN

12.4.3 SOUTH KOREA

12.4.4 INDIA

12.4.5 AUSTRALIA

12.4.6 SINGAPORE

12.4.7 MALAYSIA

12.4.8 THAILAND

12.4.9 INDONESIA

12.4.10 PHILIPPINES

12.4.11 REST OF ASIA-PACIFIC

12.5 SOUTH AMERICA

12.5.1 BRAZIL

12.5.2 REST OF SOUTH AMERICA

12.6 MIDDLE EAST & AFRICA

12.6.1 SOUTH AFRICA

12.6.2 ISRAEL

12.6.3 REST OF MIDDLE EAST & AFRICA

13 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3 COMPANY SHARE ANALYSIS: EUROPE

13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT & DBMR ANALYSIS

15 COMPANY PROFILE

15.1 DANAHER

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENEUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 MERCK KGAA

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 SERVICE PORTFOLIO

15.2.5 PRODUCT PORTFOLIO

15.2.6 RECENT DEVELOPMENT

15.3 GENERAL ELECTRIC

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENEUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 THERMO FISHER SCIENTIFIC INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 SERVICE PORTFOLIO

15.4.5 PRODUCT PORTFOLIO

15.4.6 RECENT DEVELOPMENTS

15.5 AGILENT TECHNOLOGIES, INC.

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 EUROFINS SCIENTIFIC

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 COMPANY SHARE ANALYSIS

15.6.4 SERVICE PORTFOLIO

15.6.5 RECENT DEVELOPMENTS

15.7 ATDBIO LTD.

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 SERVICE PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 AJINOMOTO CO.,INC.

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENT

15.9 BIANOSCIENCE GMBH

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 BIO BASIC INC

15.10.1 COMPANY SNAPSHOT

15.10.2 SERVICE PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 BIOLYTIC LAB PERFORMANCE INC.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BIO-SYNTHESIS INC

15.12.1 COMPANY SNAPSHOT

15.12.2 SERVICE PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 GENSCRIPT

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENEUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENTS

15.14 KANEKA EUROGENTEC S.A.

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 SERVICE PORTFOLIO

15.14.4 RECENT DEVELOPMENTS

15.15 LGC LIMITED

15.15.1 COMPANY SNAPSHOT

15.15.2 SERVICE PORTFOLIO

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENTS

15.16 NITTO DENKO CORPORATION

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 SERVICE PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 POLYGEN GMBH

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 QIAGEN

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 QUINTARA BIOSCIENCES

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.2 TRILINK BIOTECHNOLOGIES, LLC

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 TWIST BIOSCIENCE

15.21.1 COMPANY SNAPSHOT

15.21.2 REVENEUE ANALYSIS

15.21.3 PRODUCT PORTFOLIO

15.21.4 RECENT DEVELOPMENTS

16 CONCLUSION

17 QUESTIONNAIRE

18 RELATED REPORTS

TABLE 1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 2 GLOBAL DNA OLIGONUCLEOTIDES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 3 GLOBAL RNA OLIGONUCLEOTIDES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 5 GLOBAL OLIGONUCLEOTIDE-BASED DRUGS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 GLOBAL PRIMERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 GLOBAL PROBES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 8 GLOBAL INTERMEDIATE-SCALE SYNTHESIZED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 GLOBAL LARGE-SCALE SYNTHESIZED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 10 GLOBAL LINKERS & ADAPTORS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 GLOBAL ARRAY-BASED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 13 GLOBAL INSTRUMENTS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 GLOBAL KITS & REAGENTS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 GLOBAL OTHERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 17 GLOBAL CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 GLOBAL CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 19 GLOBAL PREDESIGNED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 GLOBAL OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 GLOBAL OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 22 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 23 GLOBAL RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 GLOBAL RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 25 GLOBAL THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 GLOBAL THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 27 GLOBAL DIAGNOSTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 GLOBAL OTHERS APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 30 GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN OLIGO NUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 GLOBAL HOSPITALS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 GLOBAL OTHERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 37 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 41 NORTH AMERICA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 45 NORTH AMERICA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 46 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 47 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 48 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 49 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 50 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 51 U.S. CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 52 U.S. OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 53 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 54 U.S. RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 55 U.S. THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 56 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 57 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 58 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 59 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 60 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 61 CANADA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 62 CANADA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 63 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 64 CANADA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 65 CANADA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 66 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 67 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 68 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 69 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 70 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 71 MEXICO CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 72 MEXICO OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 73 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 74 MEXICO RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 75 MEXICO THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 76 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 77 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 78 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 79 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 80 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 81 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 82 EUROPE CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 83 EUROPE OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 84 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 85 EUROPE RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 86 EUROPE THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 87 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 88 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 89 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 90 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 91 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 92 GERMANY CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 93 GERMANY OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 94 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 95 GERMANY RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 96 GERMANY THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 97 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 98 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 99 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 100 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 101 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 102 U.K. CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 103 U.K. OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 104 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 105 U.K. RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 106 U.K. THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 107 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 108 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 109 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 110 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 111 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 112 FRANCE CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 113 FRANCE OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 114 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 115 FRANCE RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 116 FRANCE THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 117 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 118 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 119 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 120 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 121 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 122 SWITZERLAND CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 123 SWITZERLAND OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 124 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 125 SWITZERLAND RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 126 SWITZERLAND THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 127 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 128 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 129 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 130 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 131 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 132 ITALY CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 133 ITALY OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MAR KET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 134 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 135 ITALY RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 136 ITALY THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 137 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 138 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 139 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 140 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 141 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 142 BELGIUM CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 143 BELGIUM OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 144 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 145 BELGIUM RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 146 BELGIUM THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 147 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 148 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 149 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 150 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 151 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 152 DENMARK CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 153 DENMARK OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 154 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 155 DENMARK RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 156 DENMARK THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 157 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 158 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 159 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 160 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 161 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 162 SWEDEN CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 163 SWEDEN OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 164 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 165 SWEDEN RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 166 SWEDEN THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 167 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 168 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 169 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 170 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 171 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 172 SPAIN CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 173 SPAIN OLIGO SYNTHESIS IN OLI GONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 174 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 175 SPAIN RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 176 SPAIN THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 177 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 178 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 179 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 180 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 181 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SER VICE TYPE, 2017-2026 (USD MILLION)

TABLE 182 NETHERLANDS CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 183 NETHERLANDS OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 184 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 185 NETHERLANDS RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 186 NETHERLANDS THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 187 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 188 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 189 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 190 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 191 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 192 RUSSIA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 193 RUSSIA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 194 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 195 RUSSIA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 196 RUSSIA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 197 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 198 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 199 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 200 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 201 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 202 TURKEY CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 203 TURKEY OLIGO SYNTH ESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 204 TURKEY OLIGONUCLEO TIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 205 TURKEY RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 206 TURKEY THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 207 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 208 REST OF EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 209 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 210 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 211 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 212 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 213 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 214 ASIA-PACIFIC CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 215 ASIA-PACIFIC OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 216 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 217 ASIA-PACIFIC RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 218 ASIA-PACIFIC THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 219 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 220 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 221 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 222 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 223 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 224 CHINA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 225 CHINA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 226 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 227 CHINA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 228 CHINA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 229 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 230 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 231 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 232 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 233 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 234 JAPAN CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 235 JAPAN OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 236 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 237 JAPAN RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 238 JAPAN THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 239 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET, B Y END USER, 2017-2026 (USD MILLION)

TABLE 240 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 241 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 242 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 243 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 244 SOUTH KOREA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 245 SOUTH KOREA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 246 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 247 SOUTH KOREA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 248 SOUTH KOREA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 249 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 250 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 251 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 252 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 253 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 254 INDIA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 255 INDIA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 256 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 257 INDIA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 258 INDIA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 259 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 260 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 261 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 262 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 263 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 264 AUSTRALIA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 265 AUSTRALIA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTH ESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 266 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 267 AUSTRALIA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 268 AUSTRALIA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 269 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 270 SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 271 SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 272 SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 273 SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 274 SINGAPORE CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 275 SINGAPORE OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 276 SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 277 SINGAPORE RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 278 SINGAPORE THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 279 SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 280 MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 281 MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 282 MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 283 MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 284 MALAYSIA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 285 MALAYSIA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 286 MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 287 MALAYSIA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 288 MALAYSIA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 289 MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 290 THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 291 THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 292 THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 293 THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 294 THAILAND CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 295 THAILAND OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 296 THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 297 THAILAND RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 298 THAILAND THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 299 THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 300 INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 301 INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 302 INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 303 INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 304 INDONESIA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 305 INDONESIA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 306 INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 307 INDONESIA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 308 INDONESIA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 309 INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 310 PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 311 PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 312 PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 313 PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 314 PHILIPPINES CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 315 PHILIPPINES OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 316 PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 317 PHILIPPINES RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 318 PHILIPPINES THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 319 PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 320 REST OF ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 321 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 322 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 323 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 324 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 325 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 326 SOUTH AMERICA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 327 SOUTH AMERICA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 328 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 329 SOUTH AMERICA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 330 SOUTH AMERICA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 331 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 332 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 333 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 334 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 335 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 336 BRAZIL CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 337 BRAZIL OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 338 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 339 BRAZIL RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 340 BRAZIL THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 341 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 342 REST OF SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 343 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 344 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 345 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 346 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 347 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 348 MIDDLE EAST & AFRICA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 349 MIDDLE EAST & AFRICA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 350 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 351 MIDDLE EAST & AFRICA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 352 MIDDLE EAST & AFRICA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 353 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 354 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 355 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 356 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 357 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 358 SOUTH AFRICA CUSTOM OLIGOS IN OLIGONUCL EOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 359 SOUTH AFRICA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 360 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 361 SOUTH AFRICA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 362 SOUTH AFRICA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 363 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 364 ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 365 ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 366 ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 367 ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 368 ISRAEL CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 369 ISRAEL OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 370 ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 371 ISRAEL RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 372 ISRAEL THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 373 ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 374 REST OF MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

FIGURE 1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

FIGURE 2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: DATA VALIDATION MODEL

FIGURE 3 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: GLOBAL VS REGIONAL

FIGURE 5 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL OLIGONUCLEOTIDE SYSNTHESIS MARKET

FIGURE 9 INCREASING USAGE OF SYNTHESIZED OLIGOS IN MOLECULAR DIAGNOSTICS AND CLINICAL APPLICATIONS AND INCREASING GOVERNMENT INVESTMENTS, R&D EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES AND RISE IN VENTURE INVESTMENTS ARE EXPECTED TO DRIVE THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 10 DNA OLIGONUCLEOTIDES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 11 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY PRODUCT TYPE, 2018

FIGURE 12 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY TYPE, 2018

FIGURE 13 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY CONSUMABLES, 2018

FIGURE 14 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY SERVICE TYPE, 2018

FIGURE 15 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY APPLICATION, 2018

FIGURE 16 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY END USER, 2018

FIGURE 17 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: SNAPSHOT (2018)

FIGURE 18 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY GEOGRAPHY (2018)

FIGURE 19 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY GEOGRAPHY (2019 & 2026)

FIGURE 20 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY GEOGRAPHY (2018 & 2026)

FIGURE 21 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY PRODUCT TYPE (2019-2026)

FIGURE 22 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: SNAPSHOT (2018)

FIGURE 23 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018)

FIGURE 24 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 25 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY (2018 & 2026)

FIGURE 26 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE (2018 - 2026)

FIGURE 27 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET: SNAPSHOT (2018)

FIGURE 28 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018)

FIGURE 29 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 30 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY (2018 & 2026)

FIGURE 31 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE (2018 - 2026)

FIGURE 32 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET: SNAPSHOT (2018)

FIGURE 33 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018)

FIGURE 34 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 35 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY (2018 & 2026)

FIGURE 36 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET, PRODUCT TYPE (2018 - 2026)

FIGURE 37 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: SNAPSHOT (2018)

FIGURE 38 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018)

FIGURE 39 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 40 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY (2018 & 2026)

FIGURE 41 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE (2018 - 2026)

FIGURE 42 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET: SNAPSHOT (2018)

FIGURE 43 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018)

FIGURE 44 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 45 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY (2018 & 2026)

FIGURE 46 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET, PRODUCT TYPE (2018 - 2026)

FIGURE 47 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY SHARE 2018 (%)

FIGURE 48 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY SHARE 2018 (%)

FIGURE 49 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY SHARE 2018 (%)

FIGURE 50 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART